Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Peta L. S. Reeves"'
Autor:
Anthony W. Purcell, Casper G. Schalkwijk, Rochelle Ayala, David Briskey, Jean L.J.M. Scheijen, Josephine M. Forbes, Raymond J. Steptoe, Kai Lin Giam, Sherman Leung, Domenica A. McCarthy, Brooke E. Harcourt, Micheal S. Ward, Peta L. S. Reeves, Amelia K. Fotheringham, Pouya Faridi, Danielle J. Borg, Nadine L. Dudek
Publikováno v:
Metabolites
Volume 11
Issue 7
Metabolites, Vol 11, Iss 426, p 426 (2021)
Metabolites, 11(7):426. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 11
Issue 7
Metabolites, Vol 11, Iss 426, p 426 (2021)
Metabolites, 11(7):426. Multidisciplinary Digital Publishing Institute (MDPI)
Mechanisms by which advanced glycation end products (AGEs) contribute to type 1 diabetes (T1D) pathogenesis are poorly understood. Since life-long pharmacotherapy with alagebrium chloride (ALT) slows progression to experimental T1D, we hypothesized t
Autor:
Peta L. S. Reeves, Emma E. Hamilton-Williams, F. Susan Wong, Raymond J. Steptoe, Rajeev Rudraraju
Publikováno v:
European Journal of Immunology. 47:1550-1561
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T-cell tolerance and contr
Autor:
Emma E. Hamilton-Williams, Xiao Liu, Rajeev Rudraraju, Peta L. S. Reeves, Raymond J. Steptoe, F. Susan Wong
Type 1 diabetes (T1D) results from T-cell-mediated autoimmune destruction of pancreatic β cells. Effector T-cell responses emerge early in disease development and expand as disease progresses. Following β-cell destruction, a long-lived T-cell memor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa441fc80289d98734b757b6a54ea653
https://orca.cardiff.ac.uk/id/eprint/105269/1/SteptoeICBmerged_1496663775.pdf
https://orca.cardiff.ac.uk/id/eprint/105269/1/SteptoeICBmerged_1496663775.pdf
Autor:
Peta L S, Reeves, Rajeev, Rudraraju, F Susan, Wong, Emma E, Hamilton-Williams, Raymond J, Steptoe
Publikováno v:
European journal of immunology. 47(9)
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing pancreatic β cells. Therapies need to incorporate strategies to overcome the genetic defects that impair induction or maintenance of peripheral T-cell tolerance and contr
Publikováno v:
Journal of autoimmunity. 72
Reestablishment of immune tolerance to the insulin-producing beta cells is the desired goal for type 1 diabetes (T1D) treatment and prevention. Immune tolerance to multiple islet antigens is defective in individuals with T1D, but the mechanisms invol